Tonix Pharmaceuticals Holding Corp (TNXP)

[weedtrader420]

WEeeeeeeeeeeeee

[weedtrader420]

Should be fun tomorrow TNXP

[XWAVXALMIMAN]

Anyone hear the Seth Lederman interview today?

Skip to 27 minutes. This why we traded over 53 million shares today with only 31.69 million shares outstanding.

Tonix has $140 million in the bank and no debt- that’s 4.42 per share. We are grossly undervalued

[weedtrader420]

WOOHOOOOOO

[subslover]

Anything is possible but I doubt it drops below $1.00 :)

[weedtrader420]

TNXP$

[Value_Investor]

Will TNXP bounce back to $4.79 again or it will further crash to Pre-R/S Bottom $0.15 again?

[subslover]

Tonix Pharmaceuticals Announces Appointment of Sina Bavari, Ph.D. as Executive Vice President, Infectious Disease Research and Development
July 25 2022 - 07:00AM
GlobeNewswire Inc.
Alert
Print
Share On Facebook

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the appointment of Sina Bavari, Ph.D. as its new Executive Vice President, Infectious Disease Research and Development. In this role, Dr. Bavari will be responsible for leading Tonix’s development of its growing infectious disease pipeline and will serve as a key member of the Company’s executive leadership team. Dr. Bavari will be based in Frederick, Md. and, as part of his role, will oversee scientific development at Tonix’s Infectious Disease R&D Center located there.
“We are delighted that Dr. Bavari has joined our team to lead our infectious disease research and development efforts,” said Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals. “Dr. Bavari has a proven track record of innovation and of developing scientific strategies as well as leading programs at all stages of discovery and development.”

“I am excited to join Tonix and to lead the Company's efforts in infectious disease research and development programs, including vaccines in development for monkeypox, smallpox and COVID-19,” said Dr. Bavari. “The Frederick, Md. Research and Development Center, or RDC, is a state-of-the-art facility with exceptional capabilities. The facility is up and running and is staffed by an outstanding team of scientists. I look forward to leveraging my years of experience in industry and government to expedite this important work with the goal of ultimately solving health problems on a global basis.”

Dr. Bavari has a record of achievement utilizing new and complex technologies and in guiding programs through clinical decision points into advanced development. He is an inventor of approximately 30 patents, published over 300 peer-reviewed manuscripts and contributed to 15 development candidates, as well as numerous Investigational New Drug candidate filings. Most recently, he served as Chief Scientific Officer / Scientific Director at the U.S. Army Research Institute of Infectious Diseases (USAMRIID) and has held numerous leadership roles at USAMRIID, including Chief, Molecular and Translational Sciences Division and Therapeutic Discovery Center; Chief, Target Discovery & Experimental Microbiology, Integrated Toxicology Division; and Chief, Immunology, Target Identification, and Translational Research, Bacteriology Division. Dr. Bavari earned his Ph.D. in Immunotoxicology and Pharmaceutical Science at the University of Nebraska Medical Center in Omaha, Neb., and his M.S. in Nuclear Physics and Nuclear Pharmacy at the University of Southern California, Los Angeles.

Tonix Pharmaceuticals Holding Corp.*

Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s portfolio is composed of central nervous system (CNS), rare disease, immunology and infectious disease product candidates. Tonix’s CNS portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. Tonix’s lead CNS candidate, TNX-102 SL (cyclobenzaprine HCl sublingual tablet), is in mid-Phase 3 development for the management of fibromyalgia with a new Phase 3 study launched in the second quarter of 2022 and interim data expected in the first quarter of 2023. TNX-102 SL is also being developed to treat Long COVID, a chronic post-acute COVID-19 condition. Tonix expects to initiate a Phase 2 study in Long COVID in the third quarter of 2022. TNX-1300 (cocaine esterase) is a biologic designed to treat cocaine intoxication that is mid-Phase 2 and has been granted Breakthrough Therapy Designation by the FDA. TNX-1900 (intranasal potentiated oxytocin), a small molecule in development for chronic migraine, is expected to enter the clinic with a Phase 2 study in the second half of 2022. Tonix’s rare disease portfolio includes TNX-2900 (intranasal potentiated oxytocin) for the treatment of Prader-Willi syndrome. TNX-2900 has been granted Orphan-D

[Value_Investor]

Another New 52-week-low $1.53 was created last week! TNXP will hit Pre-R/S Bottom $0.15 again in the coming days/weeks before Another TOXIC Big R/S...

[XWAVXALMIMAN]

Why did CEO buy 20,000 shares at 1.71 and why did someone invest $30 million recently?

https://www.streetinsider.com/dr/news.php?id=11765760&gfv=1

https://ir.tonixpharma.com/news-events/press-releases/detail/1326/tonix-pharmaceuticals-announces-pricing-of-30-million

[Value_Investor]

New 52-week-low $1.62 so far! TNXP will hit Pre-R/S Bottom $0.15 again in the coming days/weeks before Another TOXIC Big R/S...

Sell the Biggest Pos Scam (TNXP) ASAP then use all the cash proceeds to buy a Super-Undervalued Pink-Sheet Hidden Gem at Basement to recover our Huge losses here since an excellent OTC stock can easily run 5 ~ 50-Bagger or more (such as PBHG: it did run 55-Bagger and 5.2-Bagger respectively)!

[Pennyes]

hope folks read this news between lines carefully, preferred stocks sold at a price of some $4s!?. and they can convert preferred at this issued price after certain timeline, however, this notice and press release comes at a time, the stock was just rallied upto this offering price and crashed below $2, is this not deceptive and fraudulant?.. did they bring down the price from 4-to under 2 to sell prefferred stock?...numerous questions arises by TNXPs shoddy, shaddy behaviors..!. bstds should be put in jail.

[subslover]

Tonix Pharma (TNXP) Prices $30M Convertible Redeemable Preferred Stock Placement
https://www.streetinsider.com/Corporate+News/Tonix+Pharma+%28TNXP%29+Prices+%2430M+Convertible+Redeemable+Preferred+Stock+Placement/20240318.html

[stockmavin]

Write a book about it.

[Value_Investor]

The Pos Scam just created another New low $1.63 last week! More New lows come very soon until it hits $0.15 again...

[stockmavin]

Yyyaaaawwwwnnnnnn

[Value_Investor]

This Repeated-Big-R/S & Endless-Super-Heavy-Diluting NASDAQ Pos Scam (TNXP) will crash to a New low $0.8046 from previous Bottom $4.8 since its NASDAQ peer (TBLT) had already crashed down to $3.52 so far from its previous Bottom $21!

The only hope here is, after TNXP hits its Final Bottom we might see a Quick 5.2-Bagger Huge rally to hit $4.18392 like its OTC peer (PBHG) did (from $0.0005 to $0.0026) most recently...

[stockmavin]

Much larger scams out there. Do your research.

[Value_Investor]

The Biggest NASDAQ Pos Scam (TNXP) will crash to a New low $0.9508 from previous Bottom $4.8 since its NASDAQ peer had already crashed down to $4.16 so far from previous Bottom $21!

Why this Biggest Pos Scam (TNXP) shows the FAKE OS count (15,507,674 shares on 05/17/2022) from its TA on the otcmarkets.com while TNXP actually had 18,739,988 shares OS after the 1:32 Big R/S?

https://www.otcmarkets.com/stock/TNXP/security

Who bought TNXP at $4.79 ~ $4.0 last week? Why? TNXP needs to run a 5.2-bagger Huge rally like its OTC peer did (on 12/30/2021) in order to hit $4.94416 from Bottom $0.9508! Otherwise we won't see $4.xx again in the future!

So we all should liquidate this Biggest Pos Scam (TNXP) ASAP then use all the cash proceeds to buy a Bottomed-Out OTC peer at $0.000x to recover our Huge losses here...

[Homebrew]

Reverse Split to stay on NASDAQ ?

[Pennyes]

I still stand on what I said last week, SEC must shut down TNXP
"must be SHUT Down" , it is a Scam and ponzhi schemers are behind this company and nasdaq!...gullible shareholders loose everything while ponzhi schmers fill their pockets!.

[Pennyes]

do not worry my friend, no body is blaming you, its all good,
shareholders must know what is going on out there!, that news confirms that the whole thing TNXP did is to get that notice, until next crash and another R/S and rinse, repeat activities...!.

[Pennyes]

since nasdag sent a letter, along with blood thirsty suckers called "Shorters", tnxp almost lost 50% (more than $2 from its rally two days ago?), it took 5 years to run up $2 above usual trading and but took only two days to loose it?........what kind of criminals are running stock market?

[subslover]

I really don't know. Just reporting the news.

[Pennyes]

Nasdaq scam!?...compliance garbage...!.
So the TNXP mafia did R/S and buy back stunt, just TO keep the price above $1 for 10 days so they receive this nasdaq bullshit!....nasdaq is a big scammer than TNXP!

Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

[gattes12]

Pretty soon we're going to start seeing the suckers who bought in at $4 begin the pumpity pump and tell you what a great company this is having not paid any attention to it before they thought it was going to squeeze.

[subslover]

Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
CHATHAM, N.J., June 02, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, announced today that it has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. On June 1, 2022, Tonix received a letter from The Nasdaq Stock Market LLC stating that because Tonix’s shares had a closing bid price at or above $1.00 per share for a minimum of 10 consecutive business days, Tonix’s stock had regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2), and the matter is now closed.

[dinogreeves]

Another scam from the past, 162 million in volume and only up 24%. Shame, this is going to bite the dust too. Always has been a scam, thus always will be.

[renaissance1]

I agree 100%. Total BS to do that to your shareholders. Wiped us all out right before big event. Absolutely terrible.

[Value_Investor]

The Biggest NASDAQ Pos Scam (TNXP) will crash to $1.0103 from previous Bottom $4.8 since its peer had already crashed down to $4.42 so far from previous Bottom $21!

[THEMASTERS_SON]

,,,,,,,NEXT 8K-FILING $12M-SHAREBUYBACK. WEEEEEE!

[THEMASTERS_SON]

,,,,,,,18M/OS $12M BUYBACK…U GETTING ROCKED!!!!

[Bronk]

Cause this stock looks like a steaming pile of shit. Anyone investing here is getting rocked. Flip it and that’s it

[THEMASTERS_SON]

Thanks for the $2’s MORON

[THEMASTERS_SON]

WRONG

[bcapps66]

And why is that funny?

[Bronk]

Lol anyone that bought here today is red. Yikes

[THEMASTERS_SON]

,,,,,,,BACK IN FOR 80,000

[Pennyes]

52-Week Range 1.91 - 45.44
Right now, there is "No Short Interest", possibly No shorts or shorters, this is going to work in favor of a huge rally up without any resistance!.
The shorters got "toasted" and burned, it is possible they will run away from TNXP for a long time, as there is no way in the hell the shorters can touch this with a 15M shares outstanding?.....that is like touching a "Hot iron Rod"!? Lol!

so, where is it heading now, out of 15M O/S, the share buy back quickly can grab a few million shares before the price fly high, that would be today!?. further fuel the high price!..

will it go to the 52 wk high!, well, if TNXP comes out with positive trial results and get FDA signal, sure it can touch the 52wk high of 45.44, and go beyond!, right now the whole future of this co is relies on their clinical trial results...!!.

[Pennyes]

just about to ask that question, good you did it!?, so why?.
because scam compannies and criminal managements are so greedy!?.... and Nasdag gangsters $1 minimum trade requirement might have scared the tnxp management that they will be kicked out of nasdag!...but there could be several other reasons such as having more money for themselves (most of the insider, management got their shares, which will be more valued now!?..)...

[mcjodie]

Let’s break 4!

[subslover]

Tonix's stock jumps 43% on patent for experimental pox vaccines
Published: June 1, 2022 at 9:02 a.m. ET
https://www.marketwatch.com/story/tonixs-stock-jumps-43-on-patent-for-experimental-pox-vaccines-2022-06-01

[THEMASTERS_SON]

HAHAA! 7M Vol already

[THEMASTERS_SON]

25% SHORT! BEAT THAT ASS…$11

[Fatmax88]

Why wasn’t this move done before the split?

[Pennyes]

IT IS TIME THE SEC OR SOME OTHER CORRUPT ORG MUST ACT,
SHUT DOWN THIS CO CALLED TNXP!?.

FRADULANT MANAGEMENTS R/S PONZHI SCHEME CONTINUES!!! TIME AND AGAIN1!!.. AND THEY GET AWAY FROM THIS.

[Value_Investor]

TNXP will crash down the Same percentage to $1.1748 from previous Bottom $4.8 based on its NASDAQ peer's current crashing performance (TBLT: from previous Bottom $21 to $5.1401 so far)...

[Value_Investor]

No way! TNXP will crash the Same percentage to $1.4377 from previous Bottom $4.8 based on its peer's crashing performance (TBLT: from previous Bottom $21 to $6.29 so far)...

[Kojacky]

Going significantly higher

[dancy]

hmmmmmmmmmm -wake me if they start clinical trials

TNX-801 Smallpox and Monkeypox Preventing Vaccine
Preclinical